Company newsCVS
Explain this story: Mckesson Corp Stock (MCK) Moved Up by 4.52% on Oct 1: What Investors Need To Know
McKesson Corp (MCK) saw its stock rise by 4.52% on October 1st, driven by the extension of its pharmaceutical distribution contract with CVS Health through June 2032. The company also reaffirmed its fiscal 2027 adjusted earnings outlook and long-term growth targets, with annual revenue of $403.43 billion and a net profit of $4.76 billion. Despite regulatory scrutiny and thin distribution margins, this long-term agreement enhances investor confidence and provides revenue predictability for the healthcare logistics firm.
OtherTradingKeySector and industry: HealthcareHealthcare PlansTell me moreShow less
We have not explained this story yet. The original headline, summary and link are below.
McKesson Corp (MCK) saw its stock rise by 4.52% on October 1st, driven by the extension of its pharmaceutical distribution contract with CVS Health through June 2032. The company also reaffirmed its fiscal 2027 adjusted earnings outlook and long-term growth targets, with annual revenue of $403.43 billion and a net profit of $4.76 billion. Despite regulatory scrutiny and thin distribution margins, this long-term agreement enhances investor confidence and provides revenue predictability for the healthcare logistics firm.
Article tone: Positive This describes the words the journalist used. It is not a prediction, and not advice.
Also mentioned:CVS
Published Oct 1, 2026, 12:15 ET · on this site +1h 2m